Skip to main content
. 2017 Sep 26;7(17):4217–4228. doi: 10.7150/thno.21557

Scheme 1.

Scheme 1

Optimization of ultra-small NaDyF4:x%Nd nanoagents for enhanced cancer theranostic by pH-responsive in situ aggregation.